Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters








Publication year range
1.
Vestn Ross Akad Med Nauk ; (3): 32-6, 2011.
Article in Russian | MEDLINE | ID: mdl-21542373

ABSTRACT

The literature data of the reaction of haemostatic system to antidepressants from the group of selective inhibitors of serotonin reuptake are summarized. The development of haemorrhagic complications is analyzed. The risk/benefit ratio is estimated for the treatment of depression in patients with acute myocardial infarction and stroke. A differential approach to indication of antidepressants is substantiated for the treatment of comorbid depressive disorders in different types of somatic pathology.


Subject(s)
Antidepressive Agents/adverse effects , Hemorrhage/chemically induced , Hemostasis/drug effects , Selective Serotonin Reuptake Inhibitors/adverse effects , Contraindications , Depression/complications , Depression/drug therapy , Humans , Myocardial Infarction/complications , Stroke/complications
3.
Article in Russian | MEDLINE | ID: mdl-18927974

ABSTRACT

There are two alternative points of view in the current literature addressing the mechanisms of ethyl alcohol effects on cells. A historically first appeared hypothesis of ethanol influence on living systems is based on the physical-chemical background and described the membrane-associated and intracellular biochemical events as a consequence of changes in the membrane state. In opposite, the attempts exist to differentiate the "specific action" of alcohol on separate neurochemical systems. The pharmacological belonging of ethanol to the class of CNS sedative drugs is explained in a mechanistic way through its "specific" action at GABA- and glycine-ergic systems. In the present article, the author analyses the basic results of the latter hypothesis and concludes that evidence of the existence of so-called "ethanol receptor" is insufficient.


Subject(s)
Central Nervous System Depressants/pharmacology , Ethanol/pharmacology , Receptors, GABA-A/drug effects , Animals , Brain/cytology , Brain/drug effects , Brain/metabolism , Humans , Neurons/metabolism , Receptors, GABA-A/metabolism , Signal Transduction
5.
Med Tekh ; (3): 39-43, 2004.
Article in Russian | MEDLINE | ID: mdl-15293501

ABSTRACT

An integral chip (IC) was designed for controlling the step-down pulse voltage converter, which is based on the multiphase pulse-duration modulation, for use in biomedical microprocessor systems. The CMOS technology was an optimal basis for the IC designing. An additional feedback circuit diminishes the output voltage dispersion at dynamically changing loads.


Subject(s)
Biomedical Engineering/instrumentation , Microcomputers , Electricity , Equipment Design
6.
Usp Fiziol Nauk ; 35(2): 73-91, 2004.
Article in Russian | MEDLINE | ID: mdl-15174297

ABSTRACT

The literature data devoted to endogenous allosteric regulators of membrane bound receptors are summarized in the present review. The allosteric processes are classified to (i) cooperative interaction, (ii) nonspecific, (iii) functional, and (iv) specific regulations according to target topography in a receptor. The specific endogenous allosteric regulators are described for GABAA, NMDA, muscarinic, nicotinic, serotonin, and opioid receptors. Substances of different chemical structure (peptides, lipids, and polycyclics) are able both to activate or inhibit binding and function of respective receptors. Some pathological processes appear to depend on endogenous receptor modulators. The role of the regulators is speculated in terms of receptor homeostasis, in particular, counteraction of receptor tolerance and/or sensitisation during physiological pulsation in a ligand' level in synaptic cleft.


Subject(s)
Allosteric Regulation , Cholinergic Antagonists/metabolism , GABA Antagonists/metabolism , N-Methylaspartate/metabolism , Narcotic Antagonists/metabolism , Receptors, Cell Surface/metabolism , Serotonin Antagonists/metabolism , Animals , Cholinergic Antagonists/pharmacology , Humans , N-Methylaspartate/antagonists & inhibitors , Narcotic Antagonists/pharmacology , Receptors, Cell Surface/drug effects , Serotonin Antagonists/pharmacology
7.
Biomed Khim ; 49(6): 517-41, 2003.
Article in Russian | MEDLINE | ID: mdl-16119081

ABSTRACT

Today thousands of scientific publications in the field of receptology are dedicated to allosteric regulation of receptors. Biochemical events in cardiovascular, nerve, immune, endocrine, and other systems are based on various allosteric processes. Many of pharmaceuticals exert their action via allosteric regulation of receptive structures. Unfortunately, original publications sometimes are rather fragmentary. The history, methodology, classification as well as functional aspects of allosteric regulation of receptors are reviewed in the present paper. On the basis of topography of orthosteric and allosteric receptor binding sites allosteric regulation may be subdivided into: specific, non-specific, functional, and cooperative interaction. The results of allosteric regulation of receptors by metal cations are summarized. Agonists and antagonists receptor interaction are described from the point of view of allosteric regulation.


Subject(s)
Receptors, Cell Surface , Allosteric Regulation , Animals , Humans , Ligands , Receptors, Cell Surface/agonists , Receptors, Cell Surface/antagonists & inhibitors , Receptors, Cell Surface/physiology
8.
Vopr Med Khim ; 48(5): 436-42, 2002.
Article in Russian | MEDLINE | ID: mdl-12498084

ABSTRACT

The ability of thyroliberin (TRH) to interact with opioid receptors (OR) was studied using radioligand analysis. TRH did not influence specific binding of [3H]-naloxone, but increased affinity of high affinity binding sites for the ligand in a dose-dependent manner. TRH also decreased affinity of low- affinity binding sites. Kinetic analysis of low-affinity binding sites suggests the existence of at least two subpopulations of OR, which differed in their affinity to naloxone and mode of interaction with TRH. TRH acted as non-competitive and competitive inhibitor of receptor binding sites with the lowest and moderate affinity, respectively. The allosteric pattern of TRH influence on OR with high and the lowest affinity to naloxone was suggested. TRH analogues were estimated for their ability to change in OR binding characteristics. The level of [3H]-DADL specific binding was not influenced by the peptides tested but the affinity was changed. Blind control experiment showed the ability of the TRH relative substances to increase in affinity of d-receptors could be ranked in the row: dihydroorotyl-hystidyl-prolinamide > TRH > methionyl-asparagyl-phenylalaninamide. This is consistent with ability of these compounds to influence the dopaminergic events.


Subject(s)
Brain/metabolism , Naloxone/metabolism , Receptors, Opioid/metabolism , Thyrotropin-Releasing Hormone/analogs & derivatives , Animals , Binding, Competitive , Brain/drug effects , In Vitro Techniques , Ligands , Male , Rats , Thyrotropin-Releasing Hormone/metabolism , Thyrotropin-Releasing Hormone/pharmacology
9.
Eksp Klin Farmakol ; 58(2): 51-3, 1995.
Article in Russian | MEDLINE | ID: mdl-7773093

ABSTRACT

Chronic alcoholic intoxication is followed by a fall in 3H-(D-ala-2,D-leu-5)-enkephalin affinity of mu-opioid receptors with their unchanged concentrations in the rat brain cortex, by reductions in the tissue and plasma levels of beta-endorphine and met-enkephalin. A daily administration of reaferon in a dose of 10,000 IU during two fortnights completely restored both the binding affinity of the receptors and the concentrations of the peptides tested: those of beta-endorphine in the adenohypophysis and plasma and those of metenkephalin in the adrenals and plasma.


Subject(s)
Alcohol Deterrents/therapeutic use , Alcoholism/drug therapy , Interferon Type I/therapeutic use , Receptors, Opioid/drug effects , Alcohol Deterrents/pharmacology , Alcoholism/metabolism , Animals , Brain/drug effects , Brain/metabolism , Brain Chemistry/drug effects , Drug Evaluation, Preclinical , Enkephalin, Methionine/drug effects , Enkephalin, Methionine/metabolism , Interferon Type I/pharmacology , Interferon alpha-2 , Interferon-alpha , Ligands , Male , Protein Binding/drug effects , Radioligand Assay , Rats , Receptors, Opioid/analysis , Receptors, Opioid/metabolism , Recombinant Proteins , beta-Endorphin/drug effects , beta-Endorphin/metabolism
10.
Vopr Med Khim ; 39(3): 43-5, 1993.
Article in Russian | MEDLINE | ID: mdl-8392770

ABSTRACT

Binding properties of opiate receptors were studied in brain tissue of alcoholized rats after administration of the interferon-derived drug reaferon using equilibrium radioreceptor assay. Chronic alcohol intoxication was accompanied by a decrease in affinity of opiate mu-receptors for ligands in the animals with alcohol intoxication and ethanol withdrawal. Alterations in parameters of delta-reception and in content of mu-receptors were not found. Daily administration of reaferon at a dose of 10(4) U within 1.5 month did not affect these impairments, observed in rats, studied in intoxication. However, the drug reduced completely the alcohol effect on receptors during the withdrawal period. Possible normalizing effects of reaferon on the state of opiate receptors are discussed.


Subject(s)
Alcohol Drinking , Brain/metabolism , Ethanol/pharmacology , Interferon Type I/pharmacology , Receptors, Opioid, delta/metabolism , Receptors, Opioid, mu/metabolism , Animals , Binding Sites , Enkephalin, Leucine-2-Alanine/metabolism , Interferon alpha-2 , Interferon-alpha , Male , Naloxone/metabolism , Rats , Receptors, Opioid, delta/drug effects , Receptors, Opioid, mu/drug effects , Recombinant Proteins
11.
Biull Eksp Biol Med ; 109(5): 462-4, 1990 May.
Article in Russian | MEDLINE | ID: mdl-2143090

ABSTRACT

The levels of met-enkephalin (ME), beta-endorphin (BE), and alpha-interferon (a-IFN) have been determined in the human blood 1 day after dipyridamole administration. Dipyridamole led to an increase in serum a-IFN concentration up to 3 times, and to simultaneous rise of the lymphocytes ability to produce a-IFN. The content of BE did not depend on dipyridamole treatment, but ME level achieved 110 +/- 4.8 pg/ml (compare to 79.5 +/- 7.6 pg/ml in control). Positive interrelation has been found out between individual ME concentrations and lymphocyte abilities to a-IFN production with the coefficient of correlation equal to 0.69. The effect of dipyridamole on ME level is suggested to develop via a-IFN interaction with the opioid systems.


Subject(s)
Dipyridamole/pharmacology , Enkephalin, Methionine/blood , Interferon Type I/blood , beta-Endorphin/blood , Adult , Age Factors , Aged , Female , Humans , Interferon Type I/biosynthesis , Lymphocytes/metabolism , Male , Middle Aged , Time Factors
12.
Vopr Med Khim ; 36(3): 71-3, 1990.
Article in Russian | MEDLINE | ID: mdl-2382436

ABSTRACT

Content of Met-enkephalin in striatum and of beta-endorphin in rat hypophysis were estimated after administration of ethanol and alpha-interferon into the animals. Ethanol decreased Met-enkephalin content in striatum and of beta-endorphin in hypophysis. Preadministration of alpha-interferon into brain ventricles before ethanol administration led to an increase in concentration of Met-enkephalin, while content of beta-endorphin was unaltered. In peripheric administration alpha-interferon normalized content of beta-endorphin in adenohypophysis but did not affect the Met-enkephalin concentration. Effects of alpha-interferon on content of Met-enkephalin and beta-endorphin, related to dissimilar organization of the opiate systems in hypophysis and striatum tissues, are discussed.


Subject(s)
Corpus Striatum/analysis , Endorphins/analysis , Ethanol/pharmacology , Interferon Type I/pharmacology , Pituitary Gland/analysis , Animals , Enkephalin, Methionine/analysis , In Vitro Techniques , Rats
13.
Biull Eksp Biol Med ; 106(9): 307-9, 1988 Sep.
Article in Russian | MEDLINE | ID: mdl-2844322

ABSTRACT

The ability of recombinant alpha 2-interferon (reaferon) to compete for opiate binding sites with mu- and delta-selective compounds was determined. Reaferon was found to inhibit the binding of 3H-D-ala2, D-leu5-enkephalin, and Ki value calculated was equal to 8.5 +/- 2.6 U.10(-3)/ml. The mu-agonists reception levels were decreased in the presence of reaferon at concentrations above 500 U/ml; the Ki values for 3H-morphine, 3H-dihydromorphine, 3H-RX 783006 were found to be 3.25 +/- 0.35, 4.28 +/- 0.81 and 6.51 +/- 1.27 U.10(-4)/ml, respectively. When reaferon was added into reaction medium at concentrations more than 5.10(3) U/ml the specific receptor binding of opiate antagonist 3H-naloxone was demonstrated to be increased and this effect was reversed with 100 mM NaCl. The existence of allosteric reaferon binding site which coupled with naloxone sensitive receptor was suggested to explain the results obtained.


Subject(s)
Brain/metabolism , Interferon Type I/pharmacology , Interferon-alpha/pharmacology , Receptors, Opioid/metabolism , Animals , Binding, Competitive , Enkephalin, Leucine/analogs & derivatives , Enkephalin, Leucine/metabolism , Enkephalin, Leucine-2-Alanine , Enkephalin, Methionine/analogs & derivatives , Enkephalin, Methionine/metabolism , In Vitro Techniques , Interferon alpha-2 , Ligands , Male , Rats , Receptors, Opioid, delta , Receptors, Opioid, mu , Recombinant Proteins
14.
Biokhimiia ; 53(9): 1527-31, 1988 Sep.
Article in Russian | MEDLINE | ID: mdl-2849481

ABSTRACT

The binding levels and opiate receptor binding parameters were determined for 3H-naloxone in rat brain in the presence of NaCl added in vitro. An addition of NaCl at concentrations of 5-35 mM to the reaction medium caused an increase in the level of the antagonist receptor binding. The maximal level of 3H-naloxone reception activation was observed in the presence of 10-20 mM NaCl and was, on the average, 25%. Both the increase in the NaCl dose in vitro and its decrease caused a gradual diminution of the Na+ effect. An analysis of opiate receptor saturation with 3H-naloxone revealed that the label interacted with one type of the binding sites irrespective of NaCl concentration. The affinity of receptor binding sites for 3H-naloxone increased already at NaCl concentration of 2.5 mM. In contrast, the apparent maximal number of binding sites did not change after NaCl addition at concentrations which coincided with the intracellular Na+ level but was decreased with an increase (up to 50-100 mM) in NaCl present in the reaction mixture. The results obtained point to the existence of two different binding sites that are coupled with the 3H-naloxone reactive opiate receptor.


Subject(s)
Brain/metabolism , Naloxone/metabolism , Receptors, Opioid/metabolism , Sodium Chloride/pharmacology , Animals , Kinetics , Male , Rats , Receptors, Opioid/drug effects
15.
Biull Eksp Biol Med ; 104(7): 87-9, 1987 Jul.
Article in Russian | MEDLINE | ID: mdl-3040148

ABSTRACT

The preferential interactions of alpha-interferon (alpha-IFN) with delta and mu opiate receptors were studied. alpha-IFN (specific antiviral activity 2 X 10(3) U/mg protein) was shown to inhibit in the competitive manner 3H-naloxone and 3H-D-ala2, D-leu5-enkephalin (3H-DADL) specific binding to opiate receptor subpopulations. alpha-IFN was much more effective in decreasing 3H-DADL than 3H-naloxone binding in opiate receptors: K1 values averaged 160 +/- 30 and 1150 +/- 80 U/ml, respectively. IFN effective concentrations inhibiting 50% of 3H-naloxone opiate receptor binding in the absence or presence of 100 mmol/l NaCl were similar, and the "sodium shift" value was equal to 1. The independence of alpha-IFN activity of the presence of NA+ cations suggests the antagonist character of alpha-IFN interaction with opiate receptors. Thus, alpha-IFN employed appears to be an alpha-selective ligand displaying the in vitro properties of "pure" morphine antagonists.


Subject(s)
Brain/drug effects , Interferon Type I/pharmacology , Receptors, Opioid/drug effects , Animals , Bacitracin/metabolism , Brain/metabolism , Drug Interactions , Enkephalin, Leucine/analogs & derivatives , Enkephalin, Leucine/metabolism , Enkephalin, Leucine-2-Alanine , Interferon Type I/metabolism , Naloxone/metabolism , Protein Binding/drug effects , Rats , Receptors, Opioid/metabolism , Tritium
17.
Biull Eksp Biol Med ; 102(8): 174-6, 1986 Aug.
Article in Russian | MEDLINE | ID: mdl-3017473

ABSTRACT

The ability of thyroliberin to interact with opiate receptors of the rat midbrain and hypothalamus has been studied. It was shown by competitive displacement analysis that thyroliberin did not replace labeled opioid peptides in opiate receptor binding sites when added in vitro at concentrations of up to 10(-5) M. The specific binding of opioid peptides was increased by 10-20% in the presence of 10(-7)-10(-6) M thyroliberin. This effect was, probably, due to the rise in the affinity of high-affinity opiate receptors. At the same time the affinity of low-affinity binding sites was decreased. It is suggested that the antagonistic properties of thyroliberin are mediated by the modulation of the binding characteristics of enkephalin-low-affinity opiate receptors.


Subject(s)
Brain/drug effects , Receptors, Opioid/drug effects , Thyrotropin-Releasing Hormone/pharmacology , Animals , Enkephalin, Leucine/analogs & derivatives , Enkephalin, Leucine/metabolism , Enkephalin, Leucine-2-Alanine , Hypothalamus/drug effects , Male , Mesencephalon/drug effects , Rats , Receptors, Opioid/metabolism
19.
Vopr Med Khim ; 28(5): 88-92, 1982.
Article in Russian | MEDLINE | ID: mdl-6294993

ABSTRACT

Using the method of competitive displacement of 3H-labelled naloxone, (D-ala2)-met enkephalinamide or (D-ala2)-D-leu-enkephalin by salsolinol, 1-methyl-6-hydroxy-1, 2, 3, 4-tetrahydro-beta-carboline or 1-methyl-6-methoxy-1, 2, 3, 4-tetrahydro-beta-carboline from opiate receptors, it was shown that the alkaloids studied were capable to cause specific interactions with rat hypothalamus and midbrain however, exhibiting distinctly less affinity as compared with morphine or its analogs. The sodium ratios, determined from the effective doses of the tetrahydroisoquinoline alkaloids corresponding to the alkaloid concentrations, which induce 50% displacement of 3H-naloxone from the opiate receptors in the presence or absence of 100 mM NaCl, have been found to be 0.75 for salsolinol and 3.6 for beta-carbolines studied. The data obtained suggest that salsolinol, similar to naloxone, is a "pure" morphine antagonist, whereas the beta-carbolines studied may be classified with the agonist-antagonist type. A considerable decrease in the affinity of mu-type opiate receptors has been found in presence of salsolinol in the incubation medium. The possible mechanisms of pharmacological action of the alkaloids and their relation to development of alcohol dependence and tolerance are discussed.


Subject(s)
Hypothalamus/drug effects , Isoquinolines/pharmacology , Mesencephalon/drug effects , Receptors, Opioid/drug effects , Salsoline Alkaloids/pharmacology , Alcoholism/physiopathology , Animals , Binding, Competitive , Dose-Response Relationship, Drug , Enkephalin, Leucine/physiology , Humans , In Vitro Techniques , Male , Morphine/pharmacology , Naloxone/pharmacology , Rats , Rats, Inbred Strains , Receptors, Opioid/physiology , Sodium/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL